Holen Sie sich die Stockscreener-App
10.92
4.55%
-0.52
Handel nachbörslich:
10.89
-0.03
-0.27%
Schlusskurs vom Vortag:
$11.44
Offen:
$11.3
24-Stunden-Volumen:
1.69M
Relative Volume:
3.26
Marktkapitalisierung:
$449.90M
Einnahmen:
$324.01M
Nettoeinkommen (Verlust:
$-192.37M
KGV:
-2.2845
EPS:
-4.78
Netto-Cashflow:
$-23.46M
1W Leistung:
-14.95%
1M Leistung:
-18.93%
6M Leistung:
+18.82%
1J Leistung:
+16.17%
1-Tages-Spanne:
$10.60
$11.45
1-Wochen-Bereich:
$10.60
$13.37
52-Wochen-Spanne:
$8.27
$13.99
Angiodynamic Inc Stock (ANGO) Company Profile
Firmenname
Angiodynamic Inc
Sektor
Telefon
(518) 798-1215
Adresse
14 PLAZA DRIVE, LATHAM
Vergleichen Sie ANGO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
10.92 | 471.33M | 324.01M | -192.37M | -23.46M | -4.78 |
|
ISRG
Intuitive Surgical Inc
|
592.27 | 210.16B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
202.71 | 58.51B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.01 | 40.19B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
248.16 | 36.37B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
40.43 | 31.30B | 27.43B | 1.27B | 1.01B | 1.5829 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-16 | Eingeleitet | Lake Street | Buy |
| 2024-04-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-09-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-17 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | Eingeleitet | Oppenheimer | Perform |
| 2020-11-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | Herabstufung | Craig Hallum | Buy → Hold |
| 2017-04-07 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-03-30 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | Eingeleitet | Barclays | Equal Weight |
| 2016-11-04 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-04-08 | Fortgesetzt | Piper Jaffray | Neutral |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-11-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | Bestätigt | Canaccord Genuity | Hold |
| 2012-06-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | Hochstufung | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | Herabstufung | Wedbush | Neutral → Underperform |
| 2010-09-08 | Bestätigt | Wedbush | Neutral |
Alle ansehen
Angiodynamic Inc Aktie (ANGO) Neueste Nachrichten
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2026 Earnings Call Transcript - Insider Monkey
ANGIODYNAMICS INC SEC 10-Q Report - TradingView — Track All Markets
AngioDynamics Inc (ANGO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
AngioDynamics, Inc. Revises Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Why AngioDynamics Stock Is Sinking Today - The Motley Fool
Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8% - AlphaStreet
Why hedge funds are buying AngioDynamics Inc. stock2026 world cup usa national team third place match young talents pressing system match prediction breakdown - ulpravda.ru
AngioDynamics, Microchip Technology And 3 Stocks To Watch Heading Into Tuesday - Benzinga
Aug Decliners: Will AngioDynamics Inc stock benefit from AI adoptionBear Alert & Accurate Entry/Exit Alerts - moha.gov.vn
AngioDynamics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Sahm
AngioDynamics: Growth Remains Under The Radar (NASDAQ:ANGO) - Seeking Alpha
Trend Recap: Why AngioDynamics Inc UG2 stock remains top ratedTrade Exit Summary & Low Risk High Reward Trade Ideas - moha.gov.vn
AngioDynamics, Inc. (NASDAQ:ANGO): When Will It Breakeven? - Yahoo Finance
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - Finviz
Medical tech company sets Jan. 6 call to share latest quarter - Stock Titan
New York medtech firm to present at J.P. Morgan healthcare conference - Stock Titan
Why AngioDynamics Inc. stock remains on buy listsWeekly Stock Summary & Fast Entry Momentum Alerts - DonanımHaber
Will AngioDynamics Inc. stock attract more institutional investorsSwing Trade & Growth Focused Stock Pick Reports - Улправда
How rising interest rates impact AngioDynamics Inc. stockTrade Entry Report & Technical Analysis for Trade Confirmation - Улправда
How the Printed Matter Doctrine Sees Through X-Ray Markers - Patently-O
PATENT—Fed. Cir.: Bard’s vascular access port patents properly invalidated despite prior jury verdict - VitalLaw.com
Armistice Capital LLC Sells 566,185 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
Panagora Asset Management Inc. Sells 138,518 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
The Market Doesn't Like What It Sees From AngioDynamics, Inc.'s (NASDAQ:ANGO) Revenues Yet - simplywall.st
AngioDynamics (NASDAQ:ANGO) Stock Rating Upgraded by Wall Street Zen - Defense World
AngioDynamics' (NASDAQ:ANGO) investors will be pleased with their notable 77% return over the last year - Yahoo Finance
Dynamic Technology Lab Private Ltd Purchases Shares of 29,317 AngioDynamics, Inc. $ANGO - MarketBeat
Buyback Watch: How rising interest rates impact AngioDynamics Inc. stockTrade Risk Summary & Weekly Top Performers Watchlists - BỘ NỘI VỤ
AXQ Capital LP Has $270,000 Holdings in AngioDynamics, Inc. $ANGO - Defense World
Envestnet Asset Management Inc. Sells 172,625 Shares of AngioDynamics, Inc. $ANGO - Defense World
Will AngioDynamics Inc. (UG2) stock maintain strong growthJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - newser.com
[8-K] ANGIODYNAMICS INC Reports Material Event | ANGO SEC FilingForm 8-K - Stock Titan
How strong is AngioDynamics Inc. stock balance sheetTake Profit & Low Risk High Reward Ideas - Fundação Cultural do Pará
Why AngioDynamics Inc. stock is in analyst buy zoneJuly 2025 Reactions & Weekly High Conviction Trade Ideas - Fundação Cultural do Pará
How AngioDynamics Inc. stock reacts to job market dataTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
AngioDynamics, Inc. $ANGO Stock Position Raised by Pier Capital LLC - MarketBeat
AngioDynamics Raises Forecast As Med Tech Sales Outperform - Finimize
Why analysts upgrade AngioDynamics Inc. stockJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - Fundação Cultural do Pará
Why analysts raise outlook for AngioDynamics Inc. (UG2) stockTrade Performance Summary & AI Driven Price Forecasts - Fundação Cultural do Pará
AngioDynamics (NASDAQ: ANGO) to join UBS Global Healthcare Conference at 8:00 a.m. ET - Stock Titan
H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance - Insider Monkey
Insider Buying: Lawrence Weiss Acquires Shares of AngioDynamics Inc (ANGO) - GuruFocus
ANGO registers 4.7M plan shares and covers 2.53M insider resales - Stock Titan
What hedge fund activity signals for AngioDynamics Inc. stock2025 Volatility Report & Verified Entry Point Signals - newser.com
Will AngioDynamics Inc. stock continue dividend increasesWeekly Trade Summary & Consistent Income Trade Recommendations - Trung tâm Dự báo KTTV quốc gia
Insider Spends US$112k Buying More Shares In AngioDynamics - Yahoo Finance
Is AngioDynamics Inc. stock a good choice for value investors2025 Valuation Update & Precise Trade Entry Recommendations - Trung tâm Dự báo KTTV quốc gia
Ideas Watch: Will AngioDynamics Inc. stock return to pre crisis levels2025 Risk Factors & Low Drawdown Trading Strategies - Trung tâm Dự báo KTTV quốc gia
Why AngioDynamics Inc. (UG2) stock trades below fair valueJuly 2025 Review & Risk Controlled Stock Alerts - newser.com
Day Trade: Is AngioDynamics Inc. stock a good choice for value investorsPortfolio Risk Summary & Long-Term Growth Portfolio Plans - Trung tâm Dự báo KTTV quốc gia
AngioDynamics, Inc. (ANGO) Stock Analysis: A 57.85% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
Finanzdaten der Angiodynamic Inc-Aktie (ANGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.44%
1.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):